Authors: Rimsza, LM Larson, RS Winter, SS Foucar, K Chong, YY Garner, KW Leith, CP

Citation: Lm. Rimsza et al., Benign hematogone-rich lymphoid proliferations can be distinguished from B-lineage acute lymphoblastic leukemia by integration of morphology, immunophenotype, adhesion molecule expression, and architectural features, AM J CLIN P, 114(1), 2000, pp. 66-75

Authors: Viswanatha, DS Foucar, K Berry, BR Gascoyne, RD Evans, HL Leith, CP

Citation: Ds. Viswanatha et al., Elastic mantle cell leukemia: An unusual presentation of blastic mantle cell lymphoma, MOD PATHOL, 13(7), 2000, pp. 825-833

Authors: Chauncey, TR Rankin, C Anderson, JE Chen, IM Kopecky, KJ Godwin, JE Kalaycio, ME Moore, DF Shurafa, MS Petersdorf, SH Kraut, EH Leith, CP Head, DR Luthardt, FW Willman, CL Appelbaum, FR

Citation: Tr. Chauncey et al., A phase I study of induction chemotherapy for older patients with newly diagnosed acute myeloid leukemia (AML) using mitoxantrone, etoposide, and theMDR modulator PSC 833: a Southwest Oncology Group study 9617, LEUK RES, 24(7), 2000, pp. 567-574

Authors: Appenzeller, P Leith, CP Foucar, K Scott, AA Bigler, CF Thompson, CT

Citation: P. Appenzeller et al., Cutaneous Waldenstrom macroglobulinemia in transformation, AM J DERMAT, 21(2), 1999, pp. 151-155

Authors: Leith, CP Kopecky, KJ Chen, IM Eijdems, L Slovak, ML McConnell, TS Head, DR Weick, J Grever, MR Appelbaum, FR Willman, CL

Citation: Cp. Leith et al., Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia. A Southwest Oncology Group Study, BLOOD, 94(3), 1999, pp. 1086-1099